GT Biopharma, Inc. (GTBP) - יתרות מזומנים בחישוב למניה

סמל תאגידי ולוגו של GT Biopharma Corporation (GTBP)

GT Biopharma, Inc. (GTBP) is implementing eco-friendly laboratory cycles for reagent disposal, which confirms the cash per share listed on GURU.Markets, where the metric is fixed at 4.68. This trend reflects a total capital burn due to the absence of commercial products, as well as the early-stage testing of immuno-oncology drugs, creating a period of laboratory anticipation without profit generation.

GTBP gtbiopharma.com: יתרות מזומנים למניה בטווח 04.07.2022 - 20.11.2026

פילוחי מדדים מקיפים ואנליטיקה עבור gtbiopharma.com (GTBP)

- פרטי פוזיציית מזומנים ותזרימי מזומנים:
ניתוח מקיף של החברה:GT Biopharma Corporation - GTBP
סחורת הדגל של GT Biopharma, Inc.

GT Biopharma, Inc. (GTBP) is actively developing its innovative TriKE platform to combat hematological diseases. An analysis of the cash per share structure determines the volume of net liquidity attributable to a single security. This metric measures financial stability, allowing for an assessment of the balance between capital security and the pace of expansion. The stable trajectory of this chart confirms market confidence in the brand's scientific potential. A high cash reserve guarantees protection against bankruptcy, supporting the fundamental strength of the price.